Lupin Unit gets USFDA nod for Imipramine Capsules

Lupin Ltd announced that its unit has received US FDA approval for Imipramine Pamoate capsules, an abbreviated new drug application (ANDA). The capsules are the generic equivalent of Mallinckrodt’s Tofranil-PM. The capsules had sales of about USD 39 million in the year 2009 in the US market.


Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video